Pfizer, Protalix In $280 Million Deal To Supply Brazil With Gaucher Drug
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Protalix have signed a $280 million seven-year agreement with Brazil to supply the nation with their Uplyso (taliglucerase) for treating Gaucher disease.